Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Brochure More information from http://www.researchandmarkets.com/reports/1504829/ Alzheimer's Disease Market Forecast Description: Valued at almost $6bn in the seven major markets in 2011 (US, Japan, France, Germany, Italy, Spain, and the UK), the Alzheimer’s disease drug market is forecast to experience double-digit growth to 2020. The catalysts for this include an aging population, earlier and improved diagnosis, and the introduction of immunotherapies that will be prescribed in addition to existing treatments. Features and benefits - Access Datamonitor’s patient-based Alzheimer’s disease market forecast in the seven major markets, with transparent methodology and clear assumptions. - Evaluate a highly granular forecast with sales value and volume projections to 2020 at the country, class, product, and indication level. - Understand Alzheimer’s disease market dynamics and which factors will lead to commercial success. - Review the products Datamonitor forecasts to launch over the next ten years, and how each subsequent launch will shape the market. Highlights - The Alzheimer’s disease market in the seven major markets is set to more than double over the next 10 years, from $5.8bn in 2011 to $14.5bn in 2020. The catalysts for this growth include an increasingly elderly population, earlier and improved diagnosis, and the introduction of immunotherapies. - Pfizer/Eisai’s Aricept (donepezil) is set to remain the highest-selling brand in 2011 with Forest/Lundbeck/Merz’s Namenda (memantine) close behind. However, the two drugs are following differing growth trajectories: Namenda’s sales will continue to rise while Aricept’s revenues are being severely eroded by generic competition. - Beta-amyloid immunotherapies such as bapineuzumab, solanezumab, and Gammagard have the potential to grow the market by $7.6bn. Datamonitor forecasts that around 600,000 patients with mild cognitive impairment or mild to moderate Alzheimer’s disease will receive immunotherapies annually by 2020 in the seven major markets. Your key questions answered - What degree of commercial success does Datamonitor forecast for key pipeline drugs? - What will the overall Alzheimer’s disease market dynamics be over the next 10 years? - How will sales of the major drug classes in Alzheimer’s disease evolve during the forecast period? - Which of the seven major markets provides the greatest opportunity for growth? - Which Alzheimer’s disease indications are the most lucrative? Contents: OVERVIEW Summary Introduction Features and benefits Research and analysis highlights Key questions answered Forecasting methodology Volume and value forecast methodology Price and compliance assumptions Disclaimer Ordering: Order Online - http://www.researchandmarkets.com/reports/1504829/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland. Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/ Order Information Please verify that the product information is correct and select the format(s) you require. Product Name: Alzheimer's Disease Market Forecast Web Address: http://www.researchandmarkets.com/reports/1504829/ Office Code: SCHL3FA7 Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User: USD 11400 Electronic (PDF) Enterprisewide: USD 28500 Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name: Mr Mrs Dr Miss Last Name: Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL) Ms Prof Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card: You will receive an email with a link to a secure webpage to enter your credit card details. Pay by check: Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland. Pay by wire transfer: Please transfer funds to: Account number 833 130 83 Sort code 98-53-30 Swift code ULSBIE2D IBAN number IE78ULSB98533083313083 Bank Address Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland. If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World